Mylan Pharmaceuticals Inc., is recalling more than 2.5 million bottles of generic Lipitor, a cholesterol-lowering statin medication known chemically as atorvastatin, due to the potential for microbial contamination. The Food and Drug Administration (FDA) has listed the issue as a Class II recall, which involves a situation in which use of or exposure to a violative product may cause temporary or medically reversible health consequences or where the probability of serious adverse health consequences is remote. Affected products were distributed nationally. The recall includes atorvastatin calcium tablets packaged in 90-count or 500-count bottles and include more than 1.2 million 10mg ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.